3 ms·
I can't imagine that personalized gene editing therapy will ever be cheaper than the current checkpoint blockade agents. It will be interesting to see if there
by ejstronge 10y ago
I can't imagine that personalized gene editing therapy will ever be cheaper than the current checkpoint blockade agents.
It will be interesting to see if there are differences in side effect profiles in the PD-1 knockout T-cells vs our current biologicals, however.
- Gatsky 10y agoI took the original comment to be asking why bother taking out PD-1 from the T-cells. The answer is that it obviates the need for checkpoint inhibitors, which you would otherwise need to administer together with the CAR T-cells for best efficacy. Maybe they meant something different. Checkpoint blockade alone is a great development, but having treated patients with these drugs, I can tell you it is far from a cure for 80% of people.